-
1
-
-
77957738116
-
Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology
-
Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology. Europace 2010;12:1360-420.
-
(2010)
Europace
, vol.12
, pp. 1360-1420
-
-
Camm, A.J.1
Kirchhof, P.2
Lip, G.Y.H.3
Schotten, U.4
Savelieva, I.5
Ernst, S.6
-
2
-
-
0025779484
-
Atrial Fibrillation as an independent risk factor for stroke: The Framingham Study
-
Wolf PA, Abbott RD, Kannel WB. Atrial Fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
-
(1991)
Stroke
, vol.22
, pp. 983-988
-
-
Wolf, P.A.1
Abbott, R.D.2
Kannel, W.B.3
-
3
-
-
80053496448
-
Cost of disorders of the brain in Europe 2010
-
Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011;21:718-79.
-
(2011)
Eur Neuropsychopharmacol
, vol.21
, pp. 718-779
-
-
Gustavsson, A.1
Svensson, M.2
Jacobi, F.3
Allgulander, C.4
Alonso, J.5
Beghi, E.6
-
4
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
Connelly SJ, Ekekowitz MD, Yusuf S, Eikelbloom J, Oldgren J, Parekh A et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361: 1139-51.
-
(2009)
N Engl J Med
, vol.361
, pp. 1139-1151
-
-
Connelly, S.J.1
Ekekowitz, M.D.2
Yusuf, S.3
Eikelbloom, J.4
Oldgren, J.5
Parekh, A.6
-
5
-
-
0030051404
-
Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation
-
Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61:755-59.
-
(1996)
Ann Thorac Surg
, vol.61
, pp. 755-759
-
-
Blackshear, J.L.1
Odell, J.A.2
-
6
-
-
0014518828
-
Atrial fibrillation: A study of atrial thrombus and systemic embolism in a necropsy material
-
Alberg H. Atrial fibrillation: a study of atrial thrombus and systemic embolism in a necropsy material. Acta Med Scand 1969;185:373-79.
-
(1969)
Acta Med Scand
, vol.185
, pp. 373-379
-
-
Alberg, H.1
-
7
-
-
0028872106
-
Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study
-
StoddardMF, Dawkins PR, Price CR,AmmashNM.Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol 1995;25:452-59.
-
(1995)
J Am Coll Cardiol
, vol.25
, pp. 452-459
-
-
Stoddard, M.F.1
Dawkins, P.R.2
Price, C.R.3
Ammash, N.M.4
-
8
-
-
0037161359
-
Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation
-
Sievert H, Lesh MD, Trepels T, Omran H, Bartorelli A, Della Bella P et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation. Circulation 2002;105:1887-9.
-
(2002)
Circulation
, vol.105
, pp. 1887-1889
-
-
Sievert, H.1
Lesh, M.D.2
Trepels, T.3
Omran, H.4
Bartorelli, A.5
Della Bella, P.6
-
9
-
-
33947587475
-
Initial worldwide experience with theWATCHMANleft atrial appendage system for stroke prevention in atrial fibrillation
-
Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG et al. Initial worldwide experience with theWATCHMANleft atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007;49:1490-5.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 1490-1495
-
-
Sick, P.B.1
Schuler, G.2
Hauptmann, K.E.3
Grube, E.4
Yakubov, S.5
Turi, Z.G.6
-
10
-
-
68349151861
-
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial
-
Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, BuchbinderMet al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534-42.
-
(2009)
Lancet
, vol.374
, pp. 534-542
-
-
Holmes, D.R.1
Reddy, V.Y.2
Turi, Z.G.3
Doshi, S.K.4
Sievert, H.5
Buchbinder, M.6
-
11
-
-
79751531253
-
Safety of percutaneous left atrial appendage closure: Results from the watchman left atrial appendage system for embolic protection in patients with af (PROTECT AF) clinical trial and the continued access registry
-
Reddy VY, Holmes DR, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) Clinical Trial and the Continued Access Registry. Circulation 2011;123:417-24.
-
(2011)
Circulation
, vol.123
, pp. 417-424
-
-
Reddy, V.Y.1
Holmes, D.R.2
Doshi, S.K.3
Neuzil, P.4
Kar, S.5
-
12
-
-
84874001138
-
Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation
-
Reddy VY, Doshi SK, Sievert H, Buchbinder M, Nuezil P, Huber K et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation. Circulation 2013;127:720-9.
-
(2013)
Circulation
, vol.127
, pp. 720-729
-
-
Reddy, V.Y.1
Doshi, S.K.2
Sievert, H.3
Buchbinder, M.4
Nuezil, P.5
Huber, K.6
-
13
-
-
0027167491
-
Long-term survival after first-ever stroke: The oxfordshire community stroke project
-
Dennis MS, Burn JP, Sandercock PA, Bamford JM,WadeDT,Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke 1993;24:796-800.
-
(1993)
Stroke
, vol.24
, pp. 796-800
-
-
Dennis, M.S.1
Burn, J.P.2
Sandercock, P.A.3
Bamford, J.M.4
Wade, D.T.5
Warlow, C.P.6
-
14
-
-
84905659102
-
-
Lauer Fischer Database. [Internet]. 2013 (cited April 2013)
-
Lauer Fischer Database. [Internet]. 2013 (cited April 2013). http://www. lauer-fischer.de/.
-
-
-
-
15
-
-
33947607758
-
The impact of atrial fibrillation on the cost of stroke: The Berlin Acute Stroke Study
-
Bruggenjurgen B, Rossnagel K, Roll S, Andersson FL, Selim D, Muller-Nordhorn J et al. The impact of atrial fibrillation on the cost of stroke: the Berlin Acute Stroke Study. Value Health 2007;10:137-43.
-
(2007)
Value Health
, vol.10
, pp. 137-143
-
-
Bruggenjurgen, B.1
Rossnagel, K.2
Roll, S.3
Andersson, F.L.4
Selim, D.5
Muller-Nordhorn, J.6
-
16
-
-
12144289437
-
Resource utilization and costs of stroke unit care in Germany
-
Dodel RC, Haacke C, Zamzow K, Paweilik S, Spottke A, Rethfeldt M et al. Resource utilization and costs of stroke unit care in Germany. Value Health 2004; 7:144-52.
-
(2004)
Value Health
, vol.7
, pp. 144-152
-
-
Dodel, R.C.1
Haacke, C.2
Zamzow, K.3
Paweilik, S.4
Spottke, A.5
Rethfeldt, M.6
-
18
-
-
84884477193
-
Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin
-
Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, RaoYet al. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin. Circ Cardiovasc Qual Outcomes 2013;6:567-74.
-
(2013)
Circ Cardiovasc Qual Outcomes
, vol.6
, pp. 567-574
-
-
Zalesak, M.1
Siu, K.2
Francis, K.3
Yu, C.4
Alvrtsyan, H.5
Rao, Y.6
-
19
-
-
67049134013
-
Costeffectiveness of warfarin: Trial versus 'real-world' stroke prevention in atrial fibrillation
-
Sorensen SV, Dewilde S, Singer DE, Goldhaber SZ, Monz BU, Plumb JM. Costeffectiveness of warfarin: trial versus 'real-world' stroke prevention in atrial fibrillation. Am Heart J 2009;157:1064-73.
-
(2009)
Am Heart J
, vol.157
, pp. 1064-1073
-
-
Sorensen, S.V.1
Dewilde, S.2
Singer, D.E.3
Goldhaber, S.Z.4
Monz, B.U.5
Plumb, J.M.6
-
20
-
-
78650999388
-
Resection of the left auricular appendix; A prophylaxis for recurrent arterial emboli
-
Madden JL. Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli. J Am Med Assoc 1949;140:769-72.
-
(1949)
J Am Med Assoc
, vol.140
, pp. 769-772
-
-
Madden, J.L.1
-
21
-
-
84879303265
-
Economic evaluation of percutaneous left atrial appendage occlusion: Dabigatran and warfarin for stroke prevention in patients with non-valvular atrial fibrillation
-
Singh SM, Micieli S, Wijeysundera HC. Economic evaluation of percutaneous left atrial appendage occlusion: dabigatran and warfarin for stroke prevention in patients with non-valvular atrial fibrillation. Circulation 2013;127:2414-23.
-
(2013)
Circulation
, vol.127
, pp. 2414-2423
-
-
Singh, S.M.1
Micieli, S.2
Wijeysundera, H.C.3
-
22
-
-
3042762615
-
Warfarin in patients with stroke and reasons for discontinuation
-
Helgason CM, Do MA, Nutescu E.Warfarin in patients with stroke and reasons for discontinuation. J Stroke Cerebrovasc Dis 2004;13:70-3.
-
(2004)
J Stroke Cerebrovasc Dis
, vol.13
, pp. 70-73
-
-
Helgason, C.M.1
Do, M.A.2
Nutescu, E.3
-
23
-
-
31944446445
-
Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry
-
Reynolds MR, Shah J, Essebag V. Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol 2006; 97:538-43.
-
(2006)
Am J Cardiol
, vol.97
, pp. 538-543
-
-
Reynolds, M.R.1
Shah, J.2
Essebag, V.3
-
24
-
-
84871194078
-
Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: Results of the European Heart Rhythm Association survey
-
Lip GYH, Dagres N, Proclemer A, Svendsen JH, Pison L, Blomstrom-Lundqvist C. Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey. Europace 2013; 15:141-3.
-
(2013)
Europace
, vol.15
, pp. 141-143
-
-
Lip, G.Y.H.1
Dagres, N.2
Proclemer, A.3
Svendsen, J.H.4
Pison, L.5
Blomstrom-Lundqvist, C.6
-
25
-
-
9544248668
-
Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial
-
Stroke Prevention in Atrial Fibrillation Investigators
-
Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996; 348:633-8.
-
(1996)
Lancet
, vol.348
, pp. 633-638
-
-
|